Self-clearance mechanism of mitochondrial E3 ligase MARCH5 contributes to mitochondria quality control

FEBS Journal

Volumn 283, Issue 2, 2016, Pages 294-304

  Kim, Song Hee ^a   Park, Yong Yea ^a   Yoo, Young Suk ^a   Cho, Hyeseong ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

E3 ubiquitin ligase; MARCH5; mitochondria; quality control; self clearance

Indexed keywords

GLYCINE; HOMODIMER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEUCINE; MARCH5 PROTEIN; MUTANT PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; MARCH5 PROTEIN, HUMAN; MEMBRANE PROTEIN; UBIQUITIN PROTEIN LIGASE;

AMINO ACID SUBSTITUTION; ARTICLE; CELL STRESS; CONTROLLED STUDY; DIMERIZATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MITOCHONDRION; MUTATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN MOTIF; SIGNAL TRANSDUCTION; UBIQUITIN PROTEASOME PATHWAY; UBIQUITINATION; GENETICS; HALF LIFE TIME; HEK293 CELL LINE; HELA CELL LINE; METABOLISM; PROTEIN MULTIMERIZATION; PROTEIN TERTIARY STRUCTURE;

AMINO ACID MOTIFS; HALF-LIFE; HEK293 CELLS; HELA CELLS; HUMANS; MEMBRANE PROTEINS; MITOCHONDRIA; MUTATION; NF-KAPPA B; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; PROTEOLYSIS; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84957429960     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.13568     Document Type: Article

References (42)

1. Keating DJ, (2008) Mitochondrial dysfunction, oxidative stress, regulation of exocytosis and their relevance to neurodegenerative diseases. J Neurochem 104, 298-305.
2. Gogvadze V, Orrenius S, &, Zhivotovsky B, (2008) Mitochondria in cancer cells: what is so special about them? Trends Cell Biol 18, 165-173.
3. Brandon M, Baldi P, &, Wallace DC, (2006) Mitochondrial mutations in cancer. Oncogene 25, 4647-4662.
4. Chen H, &, Chan DC, (2009) Mitochondrial dynamics-fusion, fission, movement, and mitophagy-in neurodegenerative diseases. Hum Mol Genet 18, R169-R176.
5. Knott AB, Perkins G, Schwarzenbacher R, &, Bossy-Wetzel E, (2008) Mitochondrial fragmentation in neurodegeneration. Nat Rev Neurosci 9, 505-518.
6. Chen H, McCaffery JM, &, Chan DC, (2007) Mitochondrial fusion protects against neurodegeneration in the cerebellum. Cell 130, 548-562.
7. Anuppalle M, Maddirevula S, Huh TL, &, Rhee M, (2013) Ubiquitin proteasome system networks in the neurological disorders. Anim Cell Syst 17, 383-387.
8. Tatsuta T, &, Langer T, (2008) Quality control of mitochondria: protection against neurodegeneration and ageing. EMBO J 27, 306-314.
9. Baker MJ, Tatsuta T, &, Langer T, (2011) Quality control of mitochondrial proteostasis. Cold Spring Harb Perspect Biol 3.
10. Baker BM, &, Haynes CM, (2011) Mitochondrial protein quality control during biogenesis and aging. Trends Biochem Sci 36, 254-261.
11. Taylor EB, &, Rutter J, (2011) Mitochondrial quality control by the ubiquitin-proteasome system. Biochem Soc Trans 39, 1509-1513.
12. Chu CT, (2010) A pivotal role for PINK1 and autophagy in mitochondrial quality control: implications for Parkinson disease. Hum Mol Genet 19, R28-R37.
13. Ashrafi G, &, Schwarz TL, (2013) The pathways of mitophagy for quality control and clearance of mitochondria. Cell Death Differ 20, 31-42.
14. Narendra DP, &, Youle RJ, (2011) Targeting mitochondrial dysfunction: role for PINK1 and Parkin in mitochondrial quality control. Antioxid Redox Signal 14, 1929-1938.
15. McLelland GL, Soubannier V, Chen CX, McBride HM, &, Fon EA, (2014) Parkin and PINK1 function in a vesicular trafficking pathway regulating mitochondrial quality control. EMBO J 33, 282-295.
16. Narendra D, Tanaka A, Suen DF, &, Youle RJ, (2008) Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 183, 795-803.
17. Haynes CM, &, Ron D, (2010) The mitochondrial UPR-protecting organelle protein homeostasis. J Cell Sci 123, 3849-3855.
18. Neutzner A, Benard G, Youle RJ, &, Karbowski M, (2008) Role of the ubiquitin conjugation system in the maintenance of mitochondrial homeostasis. Ann N Y Acad Sci 1147, 242-253.
19. Shanbhag R, Shi G, Rujiviphat J, &, McQuibban GA, (2012) The emerging role of proteolysis in mitochondrial quality control and the etiology of Parkinson's disease. Parkinsons Dis 2012, 382175.
20. Sugiura A, Yonashiro R, Fukuda T, Matsushita N, Nagashima S, Inatome R, &, Yanagi S, (2011) A mitochondrial ubiquitin ligase MITOL controls cell toxicity of polyglutamine-expanded protein. Mitochondrion 11, 139-146.
21. Yonashiro R, Sugiura A, Miyachi M, Fukuda T, Matsushita N, Inatome R, Ogata Y, Suzuki T, Dohmae N, &, Yanagi S, (2009) Mitochondrial ubiquitin ligase MITOL ubiquitinates mutant SOD1 and attenuates mutant SOD1-induced reactive oxygen species generation. Mol Biol Cell 20, 4524-4530.
22. Karbowski M, Neutzner A, &, Youle RJ, (2007) The mitochondrial E3 ubiquitin ligase MARCH5 is required for Drp1 dependent mitochondrial division. J Cell Biol 178, 71-84.
23. Park YY, Lee S, Karbowski M, Neutzner A, Youle RJ, &, Cho H, (2010) Loss of MARCH5 mitochondrial E3 ubiquitin ligase induces cellular senescence through dynamin-related protein 1 and mitofusin 1. J Cell Sci 123, 619-626.
24. Park YY, Nguyen OT, Kang H, &, Cho H, (2014) MARCH5-mediated quality control on acetylated Mfn1 facilitates mitochondrial homeostasis and cell survival. Cell Death Dis 5, e1172.
25. Nakamura N, Kimura Y, Tokuda M, Honda S, &, Hirose S, (2006) MARCH-V is a novel mitofusin 2- and Drp1-binding protein able to change mitochondrial morphology. EMBO Rep 7, 1019-1022.
26. Nagashima S, Tokuyama T, Yonashiro R, Inatome R, &, Yanagi S, (2014) Roles of mitochondrial ubiquitin ligase MITOL/MARCH5 in mitochondrial dynamics and diseases. J Biochem 155, 273-279.
27. Yonashiro R, Ishido S, Kyo S, Fukuda T, Goto E, Matsuki Y, Ohmura-Hoshino M, Sada K, Hotta H, Yamamura H, et al,. (2006) A novel mitochondrial ubiquitin ligase plays a critical role in mitochondrial dynamics. EMBO J 25, 3618-3626.
28. Zemirli N, Pourcelot M, Ambroise G, Hatchi E, Vazquez A, &, Arnoult D, (2014) Mitochondrial hyperfusion promotes NF-kappaB activation via the mitochondrial E3 ligase MULAN. FEBS J 281, 3095-3112.
29. Mendrola JM, Berger MB, King MC, &, Lemmon MA, (2002) The single transmembrane domains of ErbB receptors self-associate in cell membranes. J Biol Chem 277, 4704-4712.
30. Munter LM, Voigt P, Harmeier A, Kaden D, Gottschalk KE, Weise C, Pipkorn R, Schaefer M, Langosch D, &, Multhaup G, (2007) GxxxG motifs within the amyloid precursor protein transmembrane sequence are critical for the etiology of Abeta42. EMBO J 26, 1702-1712.
31. Overton MC, Chinault SL, &, Blumer KJ, (2003) Oligomerization, biogenesis, and signaling is promoted by a glycophorin A-like dimerization motif in transmembrane domain 1 of a yeast G protein-coupled receptor. J Biol Chem 278, 49369-49377.
32. Sulistijo ES, Jaszewski TM, &, MacKenzie KR, (2003) Sequence-specific dimerization of the transmembrane domain of the 'BH3-only' protein BNIP3 in membranes and detergent. J Biol Chem 278, 51950-51956.
33. de Bie P, &, Ciechanover A, (2011) Ubiquitination of E3 ligases: self-regulation of the ubiquitin system via proteolytic and non-proteolytic mechanisms. Cell Death Differ 18, 1393-1402.
34. Semenza GL, (2010) HIF-1: upstream and downstream of cancer metabolism. Curr Opin Genet Dev 20, 51-56.
35. King A, Selak MA, &, Gottlieb E, (2006) Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer. Oncogene 25, 4675-4682.
36. Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC, &, Schumacker PT, (1998) Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci USA 95, 11715-11720.
37. Chandel NS, McClintock DS, Feliciano CE, Wood TM, Melendez JA, Rodriguez AM, &, Schumacker PT, (2000) Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing. J Biol Chem 275, 25130-25138.
38. Sanjuan-Pla A, Cervera AM, Apostolova N, Garcia-Bou R, Victor VM, Murphy MP, &, McCreath KJ, (2005) A targeted antioxidant reveals the importance of mitochondrial reactive oxygen species in the hypoxic signaling of HIF-1alpha. FEBS Lett 579, 2669-2674.
39. Schroedl C, McClintock DS, Budinger GR, &, Chandel NS, (2002) Hypoxic but not anoxic stabilization of HIF-1alpha requires mitochondrial reactive oxygen species. Am J Physiol Lung Cell Mol Physiol 283, L922-L931.
40. Agani FH, Pichiule P, Chavez JC, &, LaManna JC, (2000) The role of mitochondria in the regulation of hypoxia-inducible factor 1 expression during hypoxia. J Biol Chem 275, 35863-35867.
41. Mansfield KD, Guzy RD, Pan Y, Young RM, Cash TP, Schumacker PT, &, Simon MC, (2005) Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-alpha activation. Cell Metab 1, 393-399.
42. Guzy RD, Hoyos B, Robin E, Chen H, Liu L, Mansfield KD, Simon MC, Hammerling U, &, Schumacker PT, (2005) Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab 1, 401-408.